Brief: Beam Therapeutics Reports Pipeline Updates And Q1 2023 Financial Results

Beam Therapeutics

10/05/2023 12:33

May 10 (Reuters) - Beam Therapeutics Inc  BEAM.O :
    * BEAM THERAPEUTICS REPORTS PIPELINE UPDATES AND FIRST
QUARTER
2023 FINANCIAL RESULTS
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE $1.1
BILLION AS OF MARCH 31, 2023
    * QTRLY NET LOSS PER SHARE $1.33
    * BEAM THERAPEUTICS - EXPECTS CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES TO FUND ANTICIPATED OPERATING EXPENSES AND
CAPEX REQUIREMENTS INTO 2025
    * Q1 EARNINGS PER SHARE VIEW $-1.34 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4HdvHc 
Further company coverage:  BEAM.O 

 ((Reuters.Briefs@thomsonreuters.com;))